Literature DB >> 2341595

Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine.

J M Zajecka, J Fawcett, C Guy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2341595     DOI： 10.1097/00004714-199004000-00033

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

Review 1.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

2.  Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment.

Authors:  Alan J. Gelenberg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-04

3.  Open-label study of duloxetine for the treatment of obsessive-compulsive disorder.

Authors:  Darin D Dougherty; Andrew K Corse; Tina Chou; Amanda Duffy; Amanda R Arulpragasam; Thilo Deckersbach; Michael A Jenike; Nancy J Keuthen
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-30       Impact factor: 5.176
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.